South Korea’s PCR systems market to grow at 4% CAGR through 2036

The adoption of these systems is expanding beyond infectious disease detection.

South Korea’s polymerase chain reaction (PCR) systems market is projected to rise at a compound annual growth rate of 4%, according to a GlobalData report.

The country made up approximately 3% of the Asia-Pacific market in 2024.

The adoption of automated PCR systems is expanding beyond infectious disease detection, with increasing use in genetic disorder screening and oncology diagnostics.

Developments, such as remote access for decentralised testing and built-in quality control, are transforming diagnostics, according to Nidhi Bharti, Medical Devices Analyst at GlobalData.

Automated PCR systems are also incorporating real-time analytics, stringent quality control measures, and remote operability features.

“Such enhancements empower laboratories to make informed, data-driven decisions and uphold precision during public health emergencies,” Bharti added.